Hinge Competitors
| HNGE Stock | 40.49 1.07 2.57% |
Hinge Health vs Indivior PLC Correlation
Good diversification
The correlation between Hinge Health and INDV is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hinge Health and INDV in the same portfolio, assuming nothing else is changed.
Moving against Hinge Stock
| 0.67 | 600763 | Top Choice Medical | PairCorr |
| 0.47 | CAH | Cardinal Health | PairCorr |
| 0.45 | 301267 | Huaxia Eye Hospital | PairCorr |
| 0.4 | FLGT | Fulgent Genetics | PairCorr |
| 0.33 | GH | Guardant Health Sell-off Trend | PairCorr |
Hinge Health Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Hinge Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Hinge and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Hinge Health does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Hinge Stock performing well and Hinge Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hinge Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| WGS | 2.53 | (0.31) | 0.00 | (0.09) | 0.00 | 5.21 | 21.84 | |||
| CRNX | 2.32 | 0.30 | 0.11 | 0.51 | 2.43 | 4.38 | 19.30 | |||
| IMVT | 2.49 | 0.50 | 0.20 | 0.90 | 2.08 | 5.31 | 20.44 | |||
| PRAX | 4.27 | 1.14 | 0.23 | (0.75) | 3.86 | 9.33 | 35.28 | |||
| VKTX | 2.88 | (0.10) | (0.02) | 0.00 | 3.42 | 7.96 | 19.06 | |||
| DYN | 4.00 | 0.21 | 0.05 | 0.22 | 4.78 | 7.01 | 58.12 | |||
| OSCR | 3.24 | (0.51) | 0.00 | (0.20) | 0.00 | 7.00 | 30.41 | |||
| AKRO | 1.14 | 0.28 | 0.22 | 0.50 | 0.63 | 3.29 | 16.73 | |||
| LNTH | 1.70 | 0.18 | 0.10 | 0.25 | 1.70 | 4.16 | 10.15 | |||
| INDV | 1.60 | 0.55 | 0.31 | (1.31) | 0.97 | 3.52 | 18.53 |
Cross Equities Net Income Analysis
Compare Hinge Health and related stocks such as GeneDx Holdings Corp, Crinetics Pharmaceuticals, and Immunovant Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WGS | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (241.3 M) | (245.4 M) | (549 M) | (175.8 M) | (52.3 M) | (47.1 M) | (49.4 M) |
| CRNX | (6 M) | (6 M) | (6 M) | (6 M) | (6 M) | (6 M) | (6 M) | (9.2 M) | (27.1 M) | (49.5 M) | (72.9 M) | (106.7 M) | (160 M) | (214.5 M) | (298.4 M) | (268.6 M) | (255.1 M) |
| IMVT | (136.7 M) | (136.7 M) | (136.7 M) | (136.7 M) | (136.7 M) | (136.7 M) | (136.7 M) | (136.7 M) | (450) | (66.4 M) | (107.4 M) | (156.7 M) | (211 M) | (259.3 M) | (413.8 M) | (450) | (472) |
| PRAX | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (26.5 M) | (35.5 M) | (61.8 M) | (166.9 M) | (213.1 M) | (123.3 M) | (182.8 M) | (164.5 M) | (172.8 M) |
| VKTX | (444) | (444) | (444) | (146.2 K) | (21.9 M) | (23.4 M) | (14.7 M) | (20.6 M) | (22.1 M) | (25.8 M) | (39.5 M) | (55 M) | (68.9 M) | (85.9 M) | (110 M) | (99 M) | (94 M) |
| DYN | 264 M | (1.6 B) | 87 M | (356 M) | (67 M) | 50 M | (1.2 B) | 76 M | (4.8 M) | (13.5 M) | (58.7 M) | (149.3 M) | (165.2 M) | (235.9 M) | (317.4 M) | (365 M) | (383.3 M) |
| OSCR | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (261.2 M) | (406.8 M) | (572.6 M) | (606.3 M) | (270.7 M) | 25.4 M | 29.2 M | 30.7 M |
| LNTH | (137.3 M) | (137.3 M) | (42 M) | (61.6 M) | (3.6 M) | (14.7 M) | 26.8 M | 123.4 M | 40.5 M | 31.7 M | (13.5 M) | (71.3 M) | 28.1 M | 326.7 M | 312.4 M | 359.3 M | 377.3 M |
| INDV | 32.1 M | 32.1 M | 32.1 M | 32.1 M | 32.1 M | 32.1 M | 32.1 M | 60.9 M | 262.7 M | 134 M | (148 M) | 205 M | (44 M) | (129 M) | 2 M | 1.8 M | 1.7 M |
Hinge Health and related stocks such as GeneDx Holdings Corp, Crinetics Pharmaceuticals, and Immunovant Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Hinge Health financial statement analysis. It represents the amount of money remaining after all of Hinge Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Hinge Health Competitive Analysis
The better you understand Hinge Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Hinge Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Hinge Health's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Hinge Health Competition Performance Charts
Five steps to successful analysis of Hinge Health Competition
Hinge Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Hinge Health in relation to its competition. Hinge Health's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Hinge Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Hinge Health's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Hinge Health, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Hinge Health position
In addition to having Hinge Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Hinge Health Correlation with its peers. For information on how to trade Hinge Stock refer to our How to Trade Hinge Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hinge Health. If investors know Hinge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hinge Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hinge Health is measured differently than its book value, which is the value of Hinge that is recorded on the company's balance sheet. Investors also form their own opinion of Hinge Health's value that differs from its market value or its book value, called intrinsic value, which is Hinge Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hinge Health's market value can be influenced by many factors that don't directly affect Hinge Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hinge Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hinge Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hinge Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.